3. Galletti R., Masciarelli S., Conti C., Matusali G., Di Renzo L., Meschini S., Arancia G., Mancini C., Mattia E.: Inhibition of Epstein-Barr virus LMP1 gene expression in B lymphocytes by antisense oligonucleotides: uptake and efficacy of lipid-based and receptor-mediated delivery system. Antiviral Res 2007, 74, 102-110.10.1016/j.antiviral.2006.09.001
7. Jeon J.P., Nam H.Y., Shim S.M., Han B.G.: Sustained viral activity of Epstein-Barr virus contributes to cellular immortalization of lymphoblastoid cell lines. Cancer Res 2004, 64, 3361-3364.10.1158/0008-5472.CAN-04-0079
8. Leight E.R., Sugden B.: EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus. Rev Virol 2000, 10, 83-100.10.1002/(SICI)1099-1654(200003/04)10:2<;83::AID-RMV262>3.0.CO;2-T
10. Rochford R., Cannon M.J., Sabbe R.E., Adusumilli K., Picchio G., Glynn J.M., Noonan D.J., Mosier D.E., Hobbs M.V.: Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol 1997, 10, 183-195.10.1089/vim.1997.10.183
11. Sato K., Misawa N., Chuanyi N., Satou Y., Iwakiri D., Matsuoka M., Takahashi R., Kuzushima K., Ito M., Takada K., Koyangi Y.: A novel animal model of Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in humanized mice. Blood 2011, 117, 5663-5673.10.1182/blood-2010-09-305979
12. Sugimoto M., Tahara H., Ide T., Furuichi Y.: Steps involved in immortalization and tumorogenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res 2004, 64, 3361-3364.10.1158/0008-5472.CAN-04-007915150084